G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 115 filers reported holding G1 THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $303,764 | +465.7% | 133,230 | +656.7% | 0.00% | – |
Q4 2023 | $53,701 | +111.8% | 17,607 | 0.0% | 0.00% | – |
Q3 2023 | $25,354 | -42.2% | 17,607 | 0.0% | 0.00% | – |
Q2 2023 | $43,841 | -15.2% | 17,607 | -8.7% | 0.00% | – |
Q1 2023 | $51,708 | -50.6% | 19,294 | 0.0% | 0.00% | – |
Q4 2022 | $104,766 | -56.9% | 19,294 | -1.0% | 0.00% | – |
Q3 2022 | $243,000 | +215.6% | 19,497 | +24.8% | 0.00% | – |
Q2 2022 | $77,000 | -92.2% | 15,625 | -88.0% | 0.00% | – |
Q1 2022 | $990,000 | -25.4% | 130,270 | +0.2% | 0.00% | – |
Q4 2021 | $1,327,000 | -21.1% | 129,969 | +3.8% | 0.00% | – |
Q3 2021 | $1,681,000 | -33.3% | 125,250 | +9.1% | 0.00% | – |
Q2 2021 | $2,520,000 | -19.9% | 114,826 | -12.2% | 0.00% | -100.0% |
Q1 2021 | $3,146,000 | +32.9% | 130,767 | -0.6% | 0.00% | 0.0% |
Q4 2020 | $2,367,000 | +46.2% | 131,535 | -6.2% | 0.00% | – |
Q3 2020 | $1,619,000 | -52.7% | 140,215 | -0.6% | 0.00% | -100.0% |
Q2 2020 | $3,421,000 | +132.2% | 141,021 | +5.5% | 0.00% | – |
Q1 2020 | $1,473,000 | -58.5% | 133,726 | -0.4% | 0.00% | -100.0% |
Q4 2019 | $3,549,000 | +17.8% | 134,301 | +1.5% | 0.00% | 0.0% |
Q3 2019 | $3,013,000 | -27.3% | 132,277 | -2.1% | 0.00% | 0.0% |
Q2 2019 | $4,144,000 | -77.6% | 135,144 | -87.9% | 0.00% | -80.0% |
Q1 2019 | $18,498,000 | -11.1% | 1,114,325 | +2.5% | 0.01% | -28.6% |
Q4 2018 | $20,814,000 | -68.6% | 1,086,910 | -14.1% | 0.01% | -58.8% |
Q3 2018 | $66,193,000 | +20.6% | 1,265,882 | +0.2% | 0.02% | +13.3% |
Q2 2018 | $54,890,000 | +1774.0% | 1,262,991 | +1497.7% | 0.02% | +1400.0% |
Q1 2018 | $2,929,000 | +403.3% | 79,051 | +169.4% | 0.00% | – |
Q4 2017 | $582,000 | +2.5% | 29,341 | +28.4% | 0.00% | – |
Q3 2017 | $568,000 | – | 22,858 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 1,423,794 | $16,445,000 | 3.96% |
Burrage Capital Management LLC | 228,597 | $2,640,000 | 2.08% |
CHI Advisors LLC | 84,000 | $970,000 | 0.34% |
Birchview Capital, LP | 80,000 | $924,000 | 0.31% |
Jackson Creek Investment Advisors LLC | 47,294 | $546,000 | 0.25% |
Rhenman & Partners Asset Management AB | 190,000 | $2,195,000 | 0.20% |
AIGEN INVESTMENT MANAGEMENT, LP | 90,985 | $1,051,000 | 0.13% |
Bellevue Group AG | 721,925 | $8,338,000 | 0.12% |
PDT Partners, LLC | 139,924 | $1,616,000 | 0.11% |
Virtus ETF Advisers LLC | 16,713 | $193,000 | 0.10% |